Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Next Science Wound Gel vs Neosporin in Chronic Wounds
NCT02138994Completed
- Sponsor
- Next Science
- Start
- Jul 2014
- Primary completion
- Mar 2016
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Next Science. Primary endpoint: Wound Size Reduction at 12 weeks. Started Jul 2014; status: completed.
Beyond the preview
Go deeper on NCT02138994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02138994.